We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
Read MoreHide Full Article
CME Group (CME - Free Report) reported first-quarter 2025 operating income of $2.80 per share, which beat the Zacks Consensus Estimate by 0.4%. The bottom line improved 12% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.).
Quarterly results benefited from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees. Increased volatility drove volumes.
Performance in Detail
CME Group’s revenues of $1.6 billion increased 10.4% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 10.6% year over year), market data and information services (up 10.9% year over year) and other (6.7% year over year). The top line, however, missed the Zacks Consensus Estimate by 0.5%.
Total expenses rose 1.1% year over year to $534.3 million, attributable to higher compensation and benefits, technology, and licensing and other fee agreements. It exceeded our estimate of $492.4 million.
Operating income increased 15.5% from the prior-year quarter to $1.1 billion. Our estimate was $1 billion.
Given heightened economic uncertainty, average daily volume (ADV) was a record 29.8 million contracts. Commodities grew 19%, financials increased 12%, and ADV outside the U.S. reached a new high of 8.8 million contracts, up 19% year over year. The total average rate per contract was 68.6 cents.
Financial Update
As of March 31, 2025, CME Group had $1.5 billion of cash and marketable securities, down 49.5% from the 2024-end level.
As of March 31, 2025, long-term debt was $3.4 billion, up 27.7% from 2024-end.
As of March 31, 2025, CME had shareholders' equity worth $26.5 billion, up 2% from the end of 2024.
Capital Deployment
CME Group declared dividends of $2.6 billion in the first quarter of 2025. It has returned over $28.6 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Nasdaq (NDAQ - Free Report) will report first-quarter 2025 results on April 24, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 77 cents, suggesting an increase of 22.2% from the year-ago quarter’s reported figure.
NDAQ’s earnings beat estimates in three of the last four quarters, while missing in one.
Intercontinental Exchange (ICE - Free Report) will report first-quarter 2025 results on May 1, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $1.70, suggesting an increase of 14.9% from the year-ago quarter’s reported figure.
ICE’s earnings beat estimates in two of the last four quarters, while meeting estimates in two.
Cboe Global Markets (CBOE - Free Report) will report first-quarter 2025 results on May 2, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $2.29, suggesting an increase of 6.5% from the year-ago quarter’s reported figure.
CBOE’s earnings beat estimates in three of the last four quarters and missed in one.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
CME Group (CME - Free Report) reported first-quarter 2025 operating income of $2.80 per share, which beat the Zacks Consensus Estimate by 0.4%. The bottom line improved 12% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.).
Quarterly results benefited from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees. Increased volatility drove volumes.
Performance in Detail
CME Group’s revenues of $1.6 billion increased 10.4% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 10.6% year over year), market data and information services (up 10.9% year over year) and other (6.7% year over year). The top line, however, missed the Zacks Consensus Estimate by 0.5%.
CME Group Inc. Price, Consensus and EPS Surprise
CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote
Total expenses rose 1.1% year over year to $534.3 million, attributable to higher compensation and benefits, technology, and licensing and other fee agreements. It exceeded our estimate of $492.4 million.
Operating income increased 15.5% from the prior-year quarter to $1.1 billion. Our estimate was $1 billion.
Given heightened economic uncertainty, average daily volume (ADV) was a record 29.8 million contracts. Commodities grew 19%, financials increased 12%, and ADV outside the U.S. reached a new high of 8.8 million contracts, up 19% year over year. The total average rate per contract was 68.6 cents.
Financial Update
As of March 31, 2025, CME Group had $1.5 billion of cash and marketable securities, down 49.5% from the 2024-end level.
As of March 31, 2025, long-term debt was $3.4 billion, up 27.7% from 2024-end.
As of March 31, 2025, CME had shareholders' equity worth $26.5 billion, up 2% from the end of 2024.
Capital Deployment
CME Group declared dividends of $2.6 billion in the first quarter of 2025. It has returned over $28.6 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.
Zacks Rank
CME currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Upcoming Releases
Nasdaq (NDAQ - Free Report) will report first-quarter 2025 results on April 24, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at 77 cents, suggesting an increase of 22.2% from the year-ago quarter’s reported figure.
NDAQ’s earnings beat estimates in three of the last four quarters, while missing in one.
Intercontinental Exchange (ICE - Free Report) will report first-quarter 2025 results on May 1, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $1.70, suggesting an increase of 14.9% from the year-ago quarter’s reported figure.
ICE’s earnings beat estimates in two of the last four quarters, while meeting estimates in two.
Cboe Global Markets (CBOE - Free Report) will report first-quarter 2025 results on May 2, before market open. The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $2.29, suggesting an increase of 6.5% from the year-ago quarter’s reported figure.
CBOE’s earnings beat estimates in three of the last four quarters and missed in one.